Difference between revisions of "Mo XM, et al. Oncol. Lett. (2014) cited as Ref 157 in DOI: 10.1038/s41392-020-0110-5 (Q9420)"
Jump to navigation
Jump to search
(Created claim: PubMed ID (P140): 25202400, #quickstatements; #temporary_batch_1590001671040) |
(Created claim: Publication Date (P100): 2014, #quickstatements; #temporary_batch_1590002823654) |
||||||||||||||
| Property / Publication Date | |||||||||||||||
| + | 2014
| ||||||||||||||
| Property / Publication Date: 2014 / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
Revision as of 19:33, 20 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Mo XM, et al. Oncol. Lett. (2014) cited as Ref 157 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Mo XM
0 references
Li HH
0 references
Liu M
0 references
2014
0 references
